Liver cancer
Results
Phase 3
This trial looked at the combination of sorafenib with chemoembolisation to treat cancer that started in the liver (primary liver cancer).
Cancer Research UK supported this trial.
Recruitment start: 19 November 2010
Recruitment end: 7 December 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Meyer
Bayer
Biocompatibles UK Limited
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University College London (UCL)
This is Cancer Research UK trial number CRUKE/08/022.
Last reviewed: 29 April 2018
CRUK internal database number: 2415